Neuropeptide CGRP Promotes Immune Homeostasis of Bacterial Meningitis by Inducing MHC-II Ubiquitination.

Therefore, we conclude that targeting the nervous system and manipulating neuroimmune communication is a promising strategy for treating intracranial infections like bacterial meningitis.